Role of the mitochondrial ATP-sensitive K+ channels in cardioprotection.
The mitochondrial ATP-sensitive K(+) (mitoK(ATP)) channel was discovered more than a decade ago. Since then, several pharmacological studies have identified agents that target this channel some of which selectively target mitoK(ATP). These and other studies have also suggested that mitoK(ATP) plays a key role in the process of ischemic preconditioning (IPC) and prevention of apoptosis. The mechanism by which mitoK(ATP) exerts its protective effects is unclear, however, changes in mitochondrial Ca(2+) uptake and levels of reactive oxygen species, and mitochondrial matrix swelling are believed to be involved. Despite major advances, several important issues regarding mitoK(ATP) remain unanswered. These questions include, but are not limited to: the molecular structure of mitoK(ATP), the downstream and upstream mechanisms that leads to IPC and cell death, and the pharmacological profile of the channel. This review attempts to provide an up-to-date overview of the role of mitoK(ATP) in cardioprotection.
Ardehali
Hossein
H
Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA. hardehal@jhmi.edu
D000818:Animals; D017209:Apoptosis; D006321:Heart / Q000502:physiology*; D006801:Humans; D019194:Ischemic Preconditioning; D008565:Membrane Proteins / Q000502:physiology*; D008954:Models, Biological; D009206:Myocardium / Q000378:metabolism*; D015221:Potassium Channels; D011817:Rabbits; D017382:Reactive Oxygen Species
D008565:Membrane Proteins; D015221:Potassium Channels; D017382:Reactive Oxygen Species; C117780:mitochondrial K(ATP) channel